USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: NANOCYTOMICS, LLC
City: EVANSTON
State: IL
Zip+4: 60201-3150
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $303,215.00 2
SBIR Phase II $1,503,205.00 1
STTR Phase I $300,000.00 1
STTR Phase II $1,508,572.00 1

Award List:

Nanocytological Fecal Assessment to Personalize Colonoscopic Surveillance

Award Year / Program / Phase: 2012 / STTR / Phase I
Agency: HHS
Research Institution: ITALIAN HOSPITAL
Principal Investigator: Hemant K. Roy – 617-638-8345
Award Amount: $300,000.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The clinical impact of the 5 million annual surveillance colonoscopies (follow up of previous neoplasia) is remarkably low (gt90% without significant neoplasia). Juxtaposed with this is the alarmingly frequent occurrence of colorectal cancers (CRCs) in… More

SBIR Phase I: Partial Wave Spectroscopic (PWS) Microscopy: an early screening for lung cancer

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: NSF
Principal Investigator: Hariharan Subramanian
Award Amount: $149,970.00
Abstract:
This Small Business Innovation Research Phase I project aims to develop and commercialize a technology that can screen patients who are at risk for lung cancer by means of a simple buccal swab of the cheek epithelium. Lung cancer is the leading cause of cancer deaths in the U.S. The reason for the… More

COLORECTAL CANCER (CRC) SCREENING VIA RECTAL NANOCYTOLOGY

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Hariharan Subramanian – 847-467-3216
Award Amount: $153,245.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this small business innovation research grant is to develop and commercialize a highly accurate, minimally invasive risk stratification technique for colorectal cancer (CRC) that is simple enough to be performed by the primary care provider during an… More

Nanocytological Fecal Assessment to Personalize Colonoscopic Surveillance

Award Year / Program / Phase: 2013 / STTR / Phase II
Agency: HHS
Research Institution: NORTHSHORE UNIVERSITY HEALTH SYSTEMS
Principal Investigator: Hemant K. Roy – 617-638-8345
Award Amount: $1,508,572.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The clinical impact of the 5 million annual surveillance colonoscopies (follow up of previous neoplasia) is remarkably low (gt90% without significant neoplasia). Juxtaposed with this is the alarmingly frequent occurrence of colorectal cancers (CRCs) in between… More

COLORECTAL CANCER (CRC) SCREENING VIA RECTAL NANOCYTOLOGY

Award Year / Program / Phase: 2013 / SBIR / Phase II
Agency: HHS
Principal Investigator: Hariharan Subramanian – 847-467-3216
Award Amount: $1,503,205.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this small business innovation research grant is to develop and commercialize a highly accurate, minimally invasive risk stratification technique for colorectal cancer (CRC) that is simple enough to be performed by the primary care provider during an… More